The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1508
November 21, 2016
View Complete Issue         Table of Contents 2019 
Minimed 670G: A Hybrid Closed-Loop Insulin Delivery System
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Minimed 670G: A Hybrid Closed-Loop Insulin Delivery System
November 21, 2016 (Issue: 1508)
The FDA has approved the Minimed 670G (Medtronic), a hybrid closed-loop insulin delivery system for use in patients ≥14 years old with type 1 diabetes. The system uses an algorithm to automatically adjust basal insulin doses based on readings...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Minimed 670G: A Hybrid Closed-Loop Insulin Delivery System
Article code: 1508a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.